Found 5 matching trials
Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme PHASE2 The purpose of this research study is to determine if an investigational de...
Show More Location
University of Florida
Learn More & Join Trial
RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients. PHASE1 In prior trials of CMV RNA-pulsed dendritic cell vaccines, there has been a...
Show More Location
University of Florida Health Shands Hospital
Learn More & Join Trial
Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma PHASE2 This single-arm phase II study will assess the impact of tetanus pre-condit...
Show More Location
Duke University Medical Center
Learn More & Join Trial
Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia PHASE1 RATIONALE: Monoclonal antibodies, such as basiliximab, can block tumor grow...
Show More Location
Duke University Medical Center
Learn More & Join Trial
Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma PHASE1 The purpose of this study is to determine the feasibility and safety of adm...
Show More Location
Duke University Medical Center
Learn More & Join Trial